title: USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.
authors.affiliation: University of Washington, Seattle, Wash.
authors.forename: J W
authors.initials: JW
authors.lastname: Eschbach
authors.forename: M R
authors.initials: MR
authors.lastname: Downing
authors.forename: J C
authors.initials: JC
authors.lastname: Egrie
authors.forename: J K
authors.initials: JK
authors.lastname: Browne
authors.forename: J W
authors.initials: JW
authors.lastname: Adamson
mesh_terms: D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications; D015337:Multicenter Studies as Topic; D006435:Renal Dialysis; D012640:Seizures / Q000209:etiology; D014481:United States
chemical_list: D004921:Erythropoietin; D007501:Iron